| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |